UBS Group AG - SQZ BIOTECHNOLOGIES CO ownership

SQZ BIOTECHNOLOGIES CO's ticker is SQZ and the CUSIP is 78472W104. A total of 53 filers reported holding SQZ BIOTECHNOLOGIES CO in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
UBS Group AG ownership history of SQZ BIOTECHNOLOGIES CO
ValueSharesWeighting
Q2 2023$381
-74.1%
1,410
-46.3%
0.00%
Q1 2023$1,469
-81.6%
2,624
-21.4%
0.00%
Q3 2022$8,000
-20.0%
3,337
+11.5%
0.00%
Q2 2022$10,000
-92.2%
2,993
-79.0%
0.00%
Q4 2021$128,000
+26.7%
14,277
+104.0%
0.00%
Q3 2021$101,000
+87.0%
7,000
+85.8%
0.00%
Q2 2021$54,000
+170.0%
3,767
+159.3%
0.00%
Q1 2021$20,000
-25.9%
1,453
+56.2%
0.00%
Q4 2020$27,0009300.00%
Other shareholders
SQZ BIOTECHNOLOGIES CO shareholders Q2 2022
NameSharesValueWeighting ↓
Artal Group S.A. 1,606,309$1290.01%
AMERICAN INTERNATIONAL GROUP, INC. 2,517,173$202,0030.00%
Bangor Savings Bank 11,357$9110.00%
Blue Trust, Inc. 4,195$10.00%
BARCLAYS PLC 1,794$00.00%
View complete list of SQZ BIOTECHNOLOGIES CO shareholders